Views
Graph
Explorer
Focus
Down
Load 1 level
Load 2 levels
Load 3 levels
Load 4 levels
Load all levels
All
Dagre
Focus
Down
Load 1 level
Load 2 levels
Load 3 levels
Load 4 level
Load all levels
All
Tree
SpaceTree
Focus
Expanding
Load 1 level
Load 2 levels
Load 3 levels
Down
All
Down
Radial
Focus
Expanding
Load 1 level
Load 2 levels
Load 3 levels
Down
All
Down
Box
Focus
Expanding
Down
Up
All
Down
Page â
Article
Outline
Document
Down
All
Canvas
Time
Timeline
Calendar
Request email digest
Past 24 hours
Past 2 days
Past 3 days
Past week
Add
Add page
Add comment
Add citation
Edit
Edit page
Delete page
Share
Link
Bookmark
Embed
Social media
Login
Member login
Register now for a free account
đ
Commercial Serological Tests for TB
Opinion
1
#113929
Immediately related elements
How this works
-
Controlling Infectious Diseases »
Controlling Infectious Diseases
Controlling Infectious DiseasesâMapping the issues around endemic diseasesâsuch as malaria, measles, influenza, HIV, Dengue and West Nile Virusâwith the aims of identifying improved control strategies and of providing insights into to the work of mathematical biologists, epidemiologists and public health officials in this field.âF1CEB7
▲
Diseases »
Diseases
DiseasesââFFB597
▲
TB »
TB
TBâThe Wikipedia page on Tuberculosis is embedded in the Details, and will be updated whenever the Wikipedia page updates.âD3B8AB
▲
Diagnosis of Tuberculosis »
Diagnosis of Tuberculosis
Diagnosis of TuberculosisââFFB597
■
Commercial Serological Tests for TB
Commercial Serological Tests for TBââ59C6EF
●
Adverse impact on patient-safety »
Adverse impact on patient-safety
Adverse impact on patient-safetyâHigh proportions of false-positive and false-negative results adversely impact patient safety.âEF597B
●
Imprecise findings »
Imprecise findings
Imprecise findingsâCommercial serological tests for TB provide imprecise findings.âEF597B
●
Inconsistent findings »
Inconsistent findings
Inconsistent findingsâCommercial serological tests for TB provide findingsâEF597B
●
Patient-important outcomes aren't improved »
Patient-important outcomes aren't improved
Patient-important outcomes aren't improvedâThere is no evidence that existing commercial serological assays improve patient-important outcomes.âEF597B
Heading
Summary
Click the button to enter task scheduling information
Open
Details
Enter task details
Message text
Select assignee(s)
Due date (click calendar)
RadDatePicker
RadDatePicker
Open the calendar popup.
Calendar
Title and navigation
Title and navigation
<<
<
November 2024
>
<<
November 2024
S
M
T
W
T
F
S
44
27
28
29
30
31
1
2
45
3
4
5
6
7
8
9
46
10
11
12
13
14
15
16
47
17
18
19
20
21
22
23
48
24
25
26
27
28
29
30
49
1
2
3
4
5
6
7
Reminder
No reminder
1 day before due
2 days before due
3 days before due
1 week before due
Ready to post
Copy to text
Enter
Cancel
Task assignment(s) have been emailed and cannot now be altered
Lock
Cancel
Save
Comment graphing options
Choose comments:
Comment only
Whole thread
All comments
Choose location:
To a new map
To this map
New map options
Select map ontology
Options
Standard (default) ontology
College debate ontology
Hypothesis ontology
Influence diagram ontology
Story ontology
Graph to private map
Cancel
Proceed
+Commentaires (
0
)
- Commentaires
Ajouter un commentaire
Newest first
Oldest first
Show threads
+Citations (
0
)
- Citations
Ajouter une citation
List by:
Citerank
Map
+About
- About
Entrée par:
David Price
NodeID:
#113929
Node type:
Position
Date d'entrée (GMT):
7/22/2011 9:24:00 PM
Date de la derniĂšre modification (Heure GMT):
7/22/2011 9:24:00 PM
Show other editors
Corrélations entrantes:
0
Corrélations sortantes:
0
Evaluation moyenne:
0
by
0
utilisateurs
x
Select file to upload